Mental Retardation, Congenital Heart Disease, Blepharophimosis, and Hypoplastic Teeth have all been linked in several cases. Congenital Heart Disease is when there are problems with the heart at birth. Blepharophimosis is when the eye lids are shortened and the nasal bridge is flattened. Hypoplastic Teeth is when there is reduced enamel on the teeth. These conditions have been linked to mental retardation and are still being studied.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Mental Retardation, Congenital Heart Disease, Blepharophimosis, Blepharoptosis And Hypoplastic Teeth below!
For more information on how to use Laverne, please read the How to Guide.
We have 166 products for the study of Mental Retardation, Congenital Heart Disease, Blepharophimosis, Blepharoptosis And Hypoplastic Teeth that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.
Mental Retardation, Congenital Heart Disease, Blepharophimosis, Blepharoptosis And Hypoplastic Teeth is also known as Mental Retardation, Congenital Heart Disease, Blepharophimosis, Blepharoptosis, And Hypoplastic Teeth, Ohdo Blepharophimosis Syndrome.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.